Research - Vancouver, British Columbia, Canada
BioVaxys (CSE:BIOV, OTCQB:BVAXF) is a clinical stage immunotherapeutics company that is developing its viral and oncology vaccine platforms for SARS-CoV-2 and various cancers.
Outlook
Nginx
WordPress.org
Google Tag Manager
Media Temple